Maintenance of response after open-label treatment with atomoxetine hydrochloride in international European and non-European adult outpatients with attention-deficit/hyperactivity disorder: a placebo-controlled, randomised withdrawal study

• Published in: The European journal of psychiatry Vol. 27; no. 3; pp. 185 - 205
• Main Authors: Upadhyaya, Himanshu, Ramos-Quiroga, J. Antoni, Adler, Lenard A., Williams, David, Tanaka, Yoko, Lane, Jeannine R., Escobar, Rodrigo, Trzepacz, Paula, Camporeale, Angelo, Allen, Albert J.
• Format: Journal Article
• Language: English
• Published: Universidad de Zaragoza 01.07.2013
• Subjects: Atomoxetine; Attention deficit hyperactivity disorder; Behavioral Sciences; Hyperactivity; Impressions; Neurosciences; Outpatients; Psychiatry; Public, Environmental & Occupational Health; Quality of life; ADHD; Adult; Atomoxetine; Attention-deficit/hyperactivity disorder; European

Background and Objectives: We evaluated maintenance of response to atomoxetine during a 25-week, double-blind, placebo-controlled, randomised withdrawal period in adults with attention-deficit/hyperactivity disorder (ADHD) who previously responded to atomoxetine during a 12 week open-label treatment...